Antoni Camins-Espuny

Barcelona, CT 08028, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Retraction Note to: Anti-inflammatory role of leptin in glial cells through p38 MAPK pathway inhibition.

Retraction Note to: Anti-inflammatory role of leptin in glial cells through p38 MAPK pathway inhibition.

Journal: Pharmacological reports : PR

Published: September 05, 2024

Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60.

Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. Pharmaceuticals 2017, 10, 60.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 05, 2024

JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function.

JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function.

Journal: Molecular medicine (Cambridge, Mass.)

Published: December 18, 2021

Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America.

Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America.

Journal: Journal of Alzheimer's disease : JAD

Published: June 07, 2021

Correction to: Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.

Correction to: Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.

Journal: Molecular neurobiology

Published: May 06, 2020

c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments.

c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: September 05, 2019

Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.

Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.

Journal: Molecular neurobiology

Published: August 20, 2019

Current Applications of Nanoemulsions in Cancer Therapeutics.

Current Applications of Nanoemulsions in Cancer Therapeutics.

Journal: Nanomaterials (Basel, Switzerland)

Published: May 03, 2019

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia.

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 29, 2017

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment.

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 27, 2017

Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.

Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.

Journal: Molecular neurobiology

Published: July 10, 2017

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP.

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 14, 2017

Showing 1-12 of 27

Last Updated: 09/26/2026